Concurrently, METTL14 was abundantly expressed in the NAFLD mice (P < 0.05, Figure 1C and 1D), accompanied by significantly elevated serum levels of AST, ALT, TC, and TG (P < 0.05, Figure 1E–1H). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.